mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.02 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.02 |
mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.03 |
mRNA |
NSC-87877 |
GDSC1000 |
pan-cancer |
AAC |
-0.077 |
0.03 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.03 |
mRNA |
GSK429286A |
GDSC1000 |
pan-cancer |
AAC |
0.071 |
0.03 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.03 |
mRNA |
BRD-K35604418 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.03 |
mRNA |
DMOG |
GDSC1000 |
pan-cancer |
AAC |
-0.07 |
0.03 |